Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Apply
Sacituzumab Tirumotecan & Pembrolizumab
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step